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Abstract
The ventral veinless (vvl) and trachealess (trh) genes are determinants of the Drosophila trachea.
Early in development both genes are independently activated in the tracheal primordia by signals
that are ill defined. Mutants blocking JAK/STAT signaling at any level do not form a tracheal tree
suggesting that STAT92E may be an upstream transcriptional activator of the early trachea
determinants. To test this hypothesis we have searched for STAT92E responsive enhancers activating
the expression of vvl and trh in the tracheal primordia. We show that STAT92E regulated enhancers
can be rapidly and efficiently isolated by focusing the analysis on genomic regions with clusters of
putative STAT binding sites where at least some of them are phylogenetically conserved. Detailed
analysis of a vvl early tracheal enhancer shows that non-conserved sites collaborate with conserved
sites for enhancer activation. We find that STAT92E regulated enhancers can be located as far 60 kb
from the promoters. Our results indicate that vvl and trh are independently activated by STAT92E
which is the most important transcription factor required for trachea specification.
Keywords
STAT gene-regulation; Trachea specification; Ventral veinless; Trachealess; Enhancer localization;
Gene-desert
Introduction
The JAK/STAT signaling pathway is conserved from vertebrates to invertebrates (Hou et al.,
2002; Levy and Darnell, 2002). STAT proteins are transcription factors whose misregulation
in humans has been associated to various diseases including cancer. In Drosophila, JAK/STAT
signaling controls diverse developmental processes including sex specification, segmentation,
organogenesis and stem cell regulation (Arbouzova and Zeidler, 2006; Hombría and Brown,
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2002; Luo and Dearolf, 2001). The identification of the direct STAT targets is of great scientific
and medical relevance as they will help understanding how STAT controls such varied
processes. Drosophila, with its single STAT protein (STAT92E), offers an excellent model to
study this issue. In mammals the seven STAT proteins preferentially bind sites containing the
palindromic TTCnGAA sequence where n represents a number of bases from 2 to 4. The
different vertebrate STATs show specific binding preferences: STAT6 mainly binds 4n sites,
while most other STATs bind preferentially 3n sites although STAT3 can also bind 2n sites
(Decker et al., 1997; Ehret et al., 2001; Kisseleva et al., 2002). Drosophila STAT92E shows
3n site binding preference (Yan et al., 1996). However, in vitro STAT92E also binds 4n sites
with lower affinity and in vivo it can regulate target genes using both 3n and 4n sites (Rivas et
al., 2008). Identifying the genes directly regulated by STAT92E can help to understand the
general rules about how STAT proteins achieve transcriptional specificity. The expression of
several genes has been reported to be under the regulation of STAT92E and the number keeps
expanding through the use of genetic and genomic assays. However, only in few cases the
regulation has been proved to be direct by mutating the STAT92E sites either in cell lines
(SOCS36E, Raf) (Baeg et al., 2005; Kwon et al., 2000; Muller et al., 2005), or in vivo (eve,
crb, dome) (Lovegrove et al., 2006; Rivas et al., 2008; Yan et al., 1996).
The in vivo confirmation that a suspected target is directly regulated by STAT92E is a laborious
task requiring the identification of the STAT regulated enhancer in the gene of interest and the
molecular confirmation of the putative STAT sites. In this work, using as a test case the
regulation of the early Drosophila tracheal genes, we explore how comparative bioinformatics
analysis of genomic regions can be used to rapidly identify STAT regulated enhancers.
The tracheal tree of Drosophila forms a complex reproducible network of tubes capable of
directly delivering oxygen to the animal's cells. The trachea has been used as a model to study
how different signaling pathways form such stereotypic network. The tracheae originate from
10 ectodermal placodes present at stage 10 (st10) on each side of the embryo (Manning and
Krasnow, 1993). These clusters of about 80 to 90 epidermal cells are located in each segment
from the second thoracic (T2) to the eighth abdominal segment (A8). Typically, each cluster
invaginates to form the tracheal pit that then buds six branches that migrate in different
directions. The branches migrating anteriorly and posteriorly fuse to the equivalent branches
of the adjacent segments creating a continuous dorsal trunk that runs along the anterior–
posterior axis of the embryo and connects in T1 and A8 to the spiracles allowing the gas
exchange. The remaining branches target the diverse organs or fuse to other tracheal branches
(Manning and Krasnow, 1993).
Genetic analysis has shown that many signaling pathways are required to pattern this
stereotyped network. Among others the FGF, EGF, dpp/TGFß, the wg/wnt, Notch, hedgehog
and the JAK/STAT pathways are involved in different aspects of trachea morphogenesis
[reviewed in (Ghabrial et al., 2003)].
Despite much interest on trachea development little is known about the early tracheal placode
specification. The earliest sign of tracheal development is observed at st10 (about 5 h of
development at 25 °C) when thickenings of the dorsal epithelium form the tracheal placodes.
Two genes encoding transcription factors expressed at this early stage are required for the
normal trachea morphogenesis: trachealess (trh), encoding a bHLH-PAS protein (Isaac and
Andrew, 1996; Wilk et al., 1996) and ventral veinless (vvl), encoding a POU-domain protein
(Anderson et al., 1996; de Celis et al., 1995). The vvl and trh genes are the most upstream genes
with tracheal specific expression (Fig. 1A,F) and their early activation is independent of each
other (Boube et al., 2000). In trh mutant embryos the tracheal pits do not form and the tracheal
precursors stay on the embryo's surface (Isaac and Andrew, 1996; Wilk et al., 1996). In vvl
mutant embryos the tracheal pits invaginate but the cells do not branch appropriately (Anderson
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et al., 1995; de Celis et al., 1995). The trh and vvl early tracheal enhancers have not been
identified and it is not yet known what are the upstream regulators controlling their activation
in the tracheal primordium. Some reports suggest that the JAK/STAT pathway is the most
upstream activator of trh expression in the tracheal placodes (Brown et al., 2001; Chen et al.,
2002). Early vvl tracheal expression may be modulated by wg, hh and dpp but no direct
molecular evidence has been provided (de Celis et al., 1995). vvl expression in the hindgut is
activated downstream of JAK/STAT (Brown et al., 2003), but it is not known if vvl is also
controlled by JAK/STAT in the trachea. Finding the vvl cis-regulatory regions is not trivial as
the intergenic region is 144 kb long making it one of the largest in Drosophila. Here we test
if a directed approach focusing on regions that contain conserved putative STAT92E binding-
sites would help finding the enhancers without the need to methodically dissect the whole
region. Using this approach we have isolated the vvl hindgut enhancer and two independent
early trachea enhancers all of which depend on JAK/STAT activity. Molecular analysis of one
of the early tracheal enhancers confirmed that vvl is directly regulated by STAT92E. Applying
the same approach to the trh genomic region we have uncovered the STAT92E dependent
trachea enhancers. We found that in both vvl and trh the STAT92E regulated enhancers are
tens of kilobases away from the promoter. These results show that a targeted search of
phylogenetically conserved STAT92E sites can be used efficiently to uncover enhancers
dependent on STAT regulation in other genes. Our findings strongly suggest that the early
expression of both main tracheal transcription factors is regulated directly by STAT92E
underscoring the importance of the JAK/STAT pathway for trachea specification.
Materials and methods
Detection of cis-regulatory elements
We compared the genomic vvl and trh sequences of 10 Drosophila species including
Drosophila melanogaster, D. simulans, D. sechellia, D. erecta, D. yacuba, D. anannasae, D.
grimshawi, D. virilis, D. mojavensis and D. persimilis. Seven vvl regions containing conserved
putative STAT92E DNA-binding sites were tested for their cis-regulatory activity. As a control
we also chose three regions containing non-conserved STAT92E sites and two lacking
STAT92E binding sites. Flanking primers (Supplementary Table 1) were used to amplify the
D. melanogaster DNA and the fragments were first subcloned into pGEM-T easy
(PROMEGA) and then transferred to a pCaSpeR with lacZ under the control of a minimal
promoter (phs43lacZ). Using the same approach we tested eight trh genomic fragments
containing conserved putative STAT92E sites. (For flanking primers see Sup. Table 2.)
Constructs were injected in D. melanogaster by Bestgene (USA) and the Drosophila
Consolider-Ingenio 2007 transformation platform (Spain). The resulting reporter genes were
tested for expression staining with either anti-ßGal or with a lacZ RNA probe. For most
enhancers at least four independent transgenic lines were analyzed, with most lines showing
consistent patterns of expression (see Sup. Tables 4 and 5 to find the actual number of lines
analyzed for each construct).
Immunohistochemistry and RNA in situ hybridization
Embryos were fixed in 1:1 formaldehyde 4% in PBS/n-heptane for 20 min at room temperature
and stained with mouse anti-ßGal to detect reporter gene expression (PROMEGA). Standard
digoxigenin RNA in situ protocols were performed with lacZ, trh and vvl RNA probes. For
double RNA in situ the vvl probe was labeled with fluorescein RNA labeling mix and the
upd probe with DIG RNA labeling mix (Roche). Embryos were simultaneously hybridized at
55 °C overnight with both probes. We used anti-Fluorescein-POD (horseradish peroxidase) to
detect the fluorescein labeled probe developing it with DAB and hydrogen peroxide, and then
used anti-DIG-AP to detect the DIG labeled probe following the standard RNA in situ
procedures. For fluorescent double in situ-antibody stainings embryos carrying the relevant
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reporter constructs were hybridized overnight with a vvl RNA probe. The embryos were
incubated 4 h with mouse anti-ßGal and goat anti-DIG followed by an overnight incubation
with anti-ßGal and anti-goat Alexa647. Finally, on the third day the embryos were incubated
3 h with anti-mouse Alexa448 and observed under confocal microscope.
Mutation of STAT92E DNA-binding sites
Putative STAT92E sites in vvl1+2 were mutated with QuikChange (Stratagene) using the
oligos described in Supplementary Table 3.
Generation of vvl cis-regulatory upstream and downstream deletions
We deleted the vvl upstream cis-regulatory region with the FLP-FRT technique (Parks et al.,
2004) using P[BacWH]f05223, a piggyBac element inserted 4.5 kb upstream from the vvl
transcription start, and PBac[WH]f01945 that is inserted 74.5 kb upstream. The 70 kb deletion
was confirmed by PCR amplification. Besides the upstream vvl sequence, this deficiency
(named Dfvvl4) removes seven predicted genes. We also deleted part of the downstream vvl
cis-regulatory region using the PBac[WH]f07247 element, which is inserted 16 kb downstream
of the vvl transcript and PBac[WH]f03756 inserted 174 kb downstream of the vvl transcription
unit. This deficiency, named Df vvl 7247-Mis12, generates a deletion of about 158 kb affecting
10 predicted genes.
Genetic variants
We used the following null mutant alleles: Df(1)os1A (deficient for all upd ligands), and the
amorphic alleles hopC111 (for JAK), mrl6346 (for stat92E), vvlGA3, vvlH599, trh8, wgCX4. Ectopic
upd expression was induced expressing UAS-upd with the 69B-Gal4 line.
Germ line clones
Null hop embryos were induced in hopC111 FRT101/ovoD1 FRT101; hs-FLP/+ females by 1 h
heatshock at second larval instar. The adult females were mated to either wild type, vvlds1.5-
lacZ, vvl1+2-lacZ or vvl345-lacZ homozygous males. STAT92E amorph clones were induced
in hsFLP/+; FRT82B mrl6346/FRT82B ovoD L2 females and mated to FRT82B mrl6346/TM6B
males.
Results
The trh gene is expressed and required for the specification of the salivary glands and the
tracheal primordia (Fig. 1F, (Isaac and Andrew, 1996; Wilk et al., 1996)). The ventral
veinless (vvl) gene of Drosophila is required for the development of several organs including
the trachea, the midline glia, the chordotonal sensory organs and the wing (Anderson et al.,
1995; de Celis et al., 1995; Inbal et al., 2003). In contrast to the stable trh expression during
development, vvl has a very dynamic pattern (Fig. 1A–D). At stage 9 (st9) and early st10
expression first develops in the tracheal primordia (Fig. 1A) followed by expression in the
midline glial precursors. At st11 dorsal ectodermal patches of expression appear out of register
with the tracheal pits (arrows in Fig. 1B,G) and vvl expression appears in the anterior hindgut
(not shown and Fig. 1C). As the embryos mature at st11 and 12, vvl ectoderm expression
broadens up until at st13 it covers most epidermal cells from T1 to A9 (Fig. 1C). A few cells
in the trunk remain void of vvl including some sensory organs in every segment and some cells
in the anterior and posterior spiracles. At st14 the oenocytes (not shown) and a group of cells
that will integrate into the ring gland show increased levels of vvl expression (arrows in Fig.
1C–D).
Sotillos et al. Page 4
Published as: Dev Biol. 2010 April 15; 340(2): 571–582.
Sponsored D
ocum
ent 
 Sponsored D
ocum
ent 
 Sponsored D
ocum
ent
vvl expression in the trachea and hindgut primordia depends on JAK/STAT function
Past work has shown that the JAK/STAT pathway is the earliest activator of trh in the tracheal
primordia (Brown et al., 2001) but nothing is known about how the vvl early trachea expression
is activated. As STAT92E is required for trh activation, and trh is necessary to maintain vvl
expression from st11, a direct requirement of the JAK/STAT pathway for vvl tracheal activation
is difficult to ascertain. To find out if JAK/STAT is required for early vvl activation, we
carefully analyzed vvl expression in germ line mutants lacking either JAK or STAT92E before
the Trh/Vvl cross-regulatory interactions start. We observe that in stat92E and hop germ line
clone embryos (completely lacking STAT and JAK function respectively, see Materials and
methods) vvl is not expressed in the tracheal placodes at st10 and early st11 (compare Fig. 1G
and H–I), suggesting that vvl is also directly activated by STAT92E in the trachea. As
previously reported (Brown et al., 2003), we also observed that the vvl expression in the hindgut
requires JAK/STAT signaling.
vvl is an intronless gene located in a 144 kb “gene-desert” region with the closest neighboring
genes located 27 kb upstream and 117 kb downstream (Fig. 1K). In this large region only the
immediate upstream 7 kb of vvl cis-regulatory DNA have been studied (Fig. 1K orange box)
leading to the discovery of the autoregulatory RX-drf enhancer that becomes active at late st11
in the trachea, the oenocytes and the midline glia (Certel et al., 1996) (drf is a synonym for
vvl). RX-drf expression is completely dependent on the endogenous Vvl protein expression
(Certel et al., 1996; Zelzer and Shilo, 2000). Besides this autoregulatory module, no other tissue
specific enhancers have been described in this vast intergenic region. To help localizing the
vvl enhancers we generated deletions of the vvl upstream and downstream regions using the
FLP-FRT technique (see Materials and methods). Embryos homozygous for the Dfvvl4
upstream deletion (Figs. 1K and 2A) lack early st10 vvl expression in the tracheal pits, with
vvl only appearing in the trachea at late st11 (Fig. 1J compare with G). These embryos form
an aberrant tracheal tree that, as is the case in vvl null mutants, does not fuse in a longitudinal
dorsal trunk (not shown). vvl expression in the ectoderm, hindgut, st11 dorsal ectoderm patches
and midline glia is not affected in Dfvvl4 (Fig. 1J and not shown) indicating that these enhancers
lie downstream or are redundant localizing both in downstream and upstream regions. In
contrast, embryos homozygous for the downstream deletion Dfvvl7247-Mis12 (Figs. 1K and
3A) do not affect the trachea but lack hindgut expression (Fig. 1E).
Search for STAT-regulated vvl enhancers
If vvl expression was controlled directly by STAT92E, the enhancers should contain STAT92E
binding sites that would facilitate their location. We searched in the vvl genomic region for
3n (TTCnnnGAA) and 4n (TTCnnnnGAA) sequences that have been shown to be regulated
by STAT92E in vivo (Rivas et al., 2008; Yan et al., 1996). These sequences are present at 85
places in the vvl D. melanogaster intergenic region (vertical stripes in Figs. 2A and 3A), 20 of
which are conserved in the vvl genomic region of several Drosophilids (marked with an
asterisk). We made 10 reporter genes containing the putative STAT92E sites and, as control,
two lacking them testing their ability to express lacZ in D. melanogaster embryos (Sup.
Table 4). Our analysis uncovered several embryonic enhancers upstream (Fig. 2B–G) and
downstream (ds) (Fig. 3B–F) the vvl transcription unit. Among them two independent early
(st10) trachea enhancers (Fig. 2B–C), and a hindgut enhancer active from st11 (Fig. 3E–F).
We also identified other enhancers driving expression in sensory organs, ectoderm, late trachea
(st13), posterior spiracles and oenocytes (Figs. 2 and 3 and Sup. Table 4). To confirm that the
enhancers are expressed in the vvl pattern, we performed fluorescent vvl RNA in situ and ß-
Gal double staining (Sup. Fig. 2). The ß-Gal expression in vvl9 and vvl1.0 was too weak and
did not produce good double stainings. All other constructs, with the exception of the posterior
spiracle enhancer, drive ß-Gal expression in vvl expressing cells.
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As a rapid test for the requirement for JAK/STAT regulation, we analyzed the expression of
these enhancers in Dfos1A embryos. This deficiency deletes upd, upd2 and upd3 that encode
all Drosophila JAK/STAT ligands (Hombría et al., 2005). This showed that the early trachea
and the hindgut enhancers require JAK/STAT function (Figs. 2H–I and 3K). Expression of
vvlds1.7 in the posterior spiracle is also lower in Dfos1A embryos than in wild type (Fig. 3C,I),
however we believe this effect may be indirect as vvlds1.7 is activated at st14 after upd
transcription has stopped in the spiracle and there is no nuclear STAT92E in the posterior
spiracle cells (Sotillos et al., 2008) and in any case this enhancer does not normally activate
vvl transcription. In some cases a requirement of STAT92E to regulate the enhancers could not
be ascertained due to the strong morphological defects caused by the absence of JAK/STAT
function. For example, in Dfos1A embryos where the tracheal tree does not form, the absence
of vvl6 expression in the cells associated to the trachea could be an indirect effect due to the
absence of trachea. Therefore, although we cannot discard these enhancers are regulated
directly by STAT92E we will not consider them any longer.
STAT92E regulation of the vvl hindgut enhancer
The vvlds1.5 enhancer is among the fragments with more conserved putative STAT92E sites.
vvl transcription in the anterior hindgut has been proposed to be under JAK/STAT regulation
(Brown et al., 2003). The vvlds1.5 enhancer correctly reports the vvl activation (Fig. 3E–F),
however while vvl transcription in the hindgut stops at st15; lacZ in situ hybridization in
vvlds1.5 shows that this reporter is transcriptionally active up to st17 (not shown). Despite this
anomalous behavior, the enhancer's regulation up to st15 mimics that described for the
endogenous vvl transcription (Brown et al., 2003), with lack of Upd or JAK kinase resulting
in lack of hindgut activation (Fig. 3K–M); and ectopic upd overexpression with 69B-Gal4
inducing vvlds1.5 ectopic expression in the posterior hindgut (Fig. 3G). These data indicate a
correlation between the accumulation of conserved putative STAT92E sites and the presence
of enhancers whose expression depends on JAK/STAT activity.
STAT92E regulation of early vvl trachea enhancers
To confirm that JAK/STAT regulates early vvl tracheal expression we further analyzed the
vvl1+2 and vvl345 trachea primordia enhancers. Analysis of the expression of both early
enhancers by lacZ in situ shows that they drive expression very transiently at st10–st11 (Fig.
4A–B,H–I). The vvl1+2 fragment drives lacZ expression in the tracheal placodes and in smaller
spots in homologous regions of segments not forming trachea (Fig. 2B arrowheads). This
pattern resembles the expression of vvl at st10 (Fig. 1A and de Celis et al., 1995). The three
anterior spots correspond to the maxillary, labial and first thoracic segments while the two
posterior spots correspond to the abdominal 9 and 10 segments (A9–A10). The vvl345 fragment
also drives expression in the trachea from stage 10 (Figs. 4H and 2C). The main difference
with the vvl1+2 fragment expression being that the small spots anterior and posterior to the
tracheal pits are not labeled prominently.
To define at what level of the trachea morphogenetic cascade the vvl1+2 and vvl345 enhancers
are acting, we studied if their expression is affected in mutants for vvl and trh, the earliest
known tracheal specific genes (reviewed in Ghabrial et al., 2003). In vvl mutant embryos neither
construct was affected (Fig. 4D,K) and we could observe that the labeled cells invaginated but
were unable to form a normal tracheal network. These results prove that vvl1+2 and vvl345
are not autoregulatory enhancers.
As the maintenance of vvl expression in the trachea also requires Trh function (Boube et al.,
2000; Zelzer and Shilo, 2000) we tested the expression of vvl1+2 and vvl345 in trh mutants.
Both enhancers are activated normally in trh mutant embryos but the labeled cells do not
invaginate, remaining on the surface of the embryo (Fig. 4E,L). To discard a redundant function
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of trh and vvl on the activation of the early trachea enhancers we also studied their expression
in trh, vvl double mutant embryos and observed that even in this condition vvl1+2-lacZ and
vvl345-lacZ are still expressed (not shown). The above results indicate that the early vvl trachea
enhancers are controlled by the exogenous cues that define the early tracheal specification.
The WNT pathway has been suggested to be one such exogenous cue. Wg is expressed in every
segment along a dorso-ventral stripe of cells running between the tracheal pits. Inactivation of
the WNT pathway results in ectopic vvl expression in the areas between pits indicating that the
pathway represses vvl transcription (de Celis et al., 1995). In wg null mutants, we observed
ectopic expression of both vvl1+2 and vvl345 (Fig. 4F,M) indicating that vvl repression
between pits may be mediated through these enhancers. As it also happens with the vvl RNA,
the levels of expression in the tracheal pits are still higher than between pits suggesting that
other negative elements besides the WNT pathway are modulating the expression.
As shown above the early vvl trachea enhancers are not expressed in Df(1)os1A embryos (Fig.
2H–I) suggesting that the JAK/STAT pathway is the positive exogenous cue activating vvl.
However, as this mutation deletes other genes beside the upd ligands we confirmed the JAK/
STAT dependence removing the JAK kinase by generating null hopC111 germ line clones
embryos (Binari and Perrimon, 1994; Perrimon and Mahowald, 1986). As expected neither
enhancer was expressed in hopC111 embryos lacking the maternal and zygotic hop gene (Fig.
4G,N).
The early vvl trachea expression is regulated through the putative STAT92E binding sites
STAT92E mutants blocking the JAK/STAT pathway at any level of the signaling cascade do
not form a tracheal tree, a phenotype that previously has been explained by their abnormal
trh expression (Brown et al., 2001). However, the results here presented indicate that vvl is
also regulated directly by the JAK/STAT pathway.
To confirm that the early tracheal enhancers are regulated through the putative STAT92E
DNA-binding sites, we have analyzed the vvl1+2 fragment that reflects the early vvl expression.
Comparison of this 680 bp DNA fragment between several species of Drosophilidae (Stark et
al., 2007) showed 10 conserved sequence blocks in the distal two thirds of the element (Fig. 5A
and Sup. Fig. 1). Of the three putative STAT92E binding sites [TTCnnn(n)GAA] in the vvl1
+2 fragment two of them, a 3n and a 4n site, are conserved in all species while a further 3n
site is only present in D. melanogaster.
We tested the effect of mutating some combinations of the putative STAT92E binding sites in
the vvl1+2 enhancer. Single mutation of the conserved 3n site at position 86 in vvl1+2 does
not affect tracheal expression significantly (not shown). Surprisingly, simultaneous mutation
of the two conserved STAT92E sites at positions 86 and 219 only resulted in a mild decrease
of the tracheal pit expression that is more noticeable in the segments with lower levels of
expression (Fig. 5C). Mutation of all three sites reduces the expression from all segments
(Fig. 5D).
Subdivision of the vvl1+2 element into three subfragments each containing a STAT92E site
(Fig. 5A) shows that the two flanking fragments (vvl1+2MiniS1 and vvl1+2MiniS3) cannot
activate tracheal expression (Fig. 5G,I). In contrast, the central fragment (vvl1+2MiniS2) can
drive tracheal expression although its spatial restriction is less defined with some embryos
showing ectopic expression between the pits suggesting the loss of some repressor-binding site
in the deleted region (Fig. 5H). These results show that the non-conserved vvl1+2MiniS3
fragment is dispensable and cannot drive tracheal expression by itself. However, in the context
of vvl1+2, when the conserved STAT92E sites are mutant, the non-conserved site at position
508 can contribute to enhancer activation. Thus a non-conserved site in a STAT92E site cluster
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can contribute to the enhancer's expression probably by interacting with other proteins binding
to the enhancer core (vvl1+2MiniS2) that provide the tracheal activation specificity.
As we have seen, in wg mutant embryos, vvl and the early tracheal enhancers are expressed in
a continuous band of cells running along the antero-posterior axis (Fig. 4F,M). These results
indicate that the most upstream activator of vvl must be capable of activating vvl in the areas
between the tracheal pits. Both upd and upd2 are expressed in the tracheal pits at st11 (Harrison
et al., 1998; Hombría et al., 2005) but the expression of upd with respect to the trachea primordia
before the definition of the tracheal pits has not been analyzed carefully. Double RNA in
situ of upd and vvl shows that the earliest activation of vvl occurs when upd is transiently
expressed in a stripe that runs along the antero-posterior axis of the embryo just ventral to the
tracheal placodes (Fig. 5E,J). Thus the pattern of expression of upd is consistent with that
expected for the vvl trachea activator.
Search of STAT92E regulatory elements in trh
Our results suggest that a targeted phylogenetic approach could be used to find STAT92E
regulated enhancers. To prove the case for other putative STAT92E targets we tested if a similar
approach could help finding the early trh trachea enhancers. We first analyzed the
approximately 25 kb comprised between CG13884 and CG13885 including the trh introns
(Fig. 6A). In this area there are only two regions with conserved putative sites one of which,
trh24, drives expression in the anterior and posterior spiracles of the embryo and the other,
trh31, is not expressed (Fig. 6H, and not shown). We observed that further upstream of trh,
distal to CG13885, there is a gene-desert region of 40 kb with a high number of putative
STAT92E sites. Given the precedent of the distal location of the trachea vvl elements we
wondered if the trachea enhancers could locate here. We tested six fragments containing the
conserved STAT92E sites and found that while the most distal two fragments, trh75 and
trh79, are silent the other four are expressed at different stages of trachea development.
trh47 and trh66 are expressed in the trachea from st10, trh67 from st11 and trh45 from st13
(Fig. 6B–D and I). Of the three early trachea enhancers, RNA in situ with lacZ probes reveals
that trh47 and trh66 are transiently expressed from st10 to st11 while trh67 expression lasts
up to st15 (not shown). To find at what level of the trachea cascade the three early enhancers
are regulated we analyzed their expression in Dfos1A, vvl, trh and vvl trh double mutants. The
expression of all three early enhancers is affected to different degrees in Dfos1A mutant
embryos (Fig. 6E–G) and are ectopically expressed in wg mutants (Fig. 6J and not shown).
Expression of the early enhancers does not require vvl (compare Fig. 7A–C with D–F). Only
the expression of the trh67 st11 enhancer is affected in trh and in the double trh, vvl mutants
(Fig. 7G–L). Therefore, our results indicate that the trh67 st11 enhancer is autoregulatory,
while the st10 elements depend on upstream extrinsic tracheal signals. While the effect of the
lack of upd ligands on trh67 could be indirect due to the abnormal activation of trh in
Dfos1A embryos, the effect on trh66 may be direct. Surprisingly, the expression of trh47 is not
very abnormal (Fig. 6E) leaving open the possibility that there exists a still unknown exogenous
tracheal activator.
Thus, by exclusively analyzing the conserved STAT92E sites in the trh genomic region we
were able to uncover the early STAT92E regulated enhancers. It is interesting to note that there
are conserved STAT92E sites associated to late tracheal enhancers. Upd expression is
maintained on the trachea during most of embryogenesis (Harrison et al., 1998). The
association of conserved STAT92E sites to the later enhancers suggests that Upd may also
contribute to maintain trh expression in the trachea through these elements, however the
previous requirement of STAT92E for early vvl and trh activation and the effects these have
on trachea development do not allow reaching any conclusions on this respect. Taken together,
Sotillos et al. Page 8
Published as: Dev Biol. 2010 April 15; 340(2): 571–582.
Sponsored D
ocum
ent 
 Sponsored D
ocum
ent 
 Sponsored D
ocum
ent
these results confirm that a phylogenetically targeted approach is an efficient method to isolate
the STAT92E regulated enhancers.
Discussion
Mutations in STAT proteins are linked to disease in humans and in Drosophila they affect the
development of several major organs, embryo segmentation and maintenance of gonad and gut
stem cells. Finding the direct targets of STAT holds the key to understanding how such different
functions are controlled. Microarray techniques can be used to analyze at the genome level
genes that are up- or down-regulated by STAT while ChIP-chip analysis can identify DNA
regions directly bound by STAT uncovering hundreds of possible targets. However, as the
transcriptional up- or down-regulation detected in microarrays could be indirect, and STAT92E
binds chromatin without necessarily resulting in transcriptional regulation (Shi et al., 2008),
these results have to be validated by time-consuming in vivo experiments. In this work we show
that analysis of STAT92E conserved sites provides a rapid way to isolate STAT92E regulated
enhancers even in large cis-regulatory regions.
Direct analysis of phylogenetically conserved STAT92E sites successfully uncovers JAK/
STAT regulated enhancers
Mutations in the JAK/STAT pathway result in embryos only forming residual trachea
fragments. This is caused by the abnormal activation of the early tracheal genes trh and vvl
(this work and Brown et al., 2001; Chen et al., 2002) suggesting that the early trachea enhancers
may be directly regulated by STAT92E in which case the trachea enhancers would be
associated to STAT92E binding sites.
To test this we first localized in silico the putative STAT92E binding sites in the vvl 144 kb
intergenic region (Rivas et al., 2008; Yan et al., 1996). We then compared in vivo the enhancer
activity of regions that either (1) contain putative STAT92E sites that are conserved in several
Drosophila species; (2) contain non-conserved putative STAT92E sites; or (3) contain no
putative STAT92E sites. Of the 12 reporter lines made 10 have enhancer activity consistent
with harboring embryonic vvl cis-regulatory elements. The expression of the enhancers either
lacking STAT92E sites or containing non-conserved STAT92E sites is independent of JAK/
STAT function. In contrast, of the seven vvl enhancers containing conserved sites, the
expression of three of them required JAK/STAT regulation in the embryo. One of these
enhancers drives expression in the hindgut and two are expressed in the trachea at st10. These
results suggested that exclusively looking for conserved STAT92E sites would be sufficient
to localize the STAT92E regulated sites, a prediction we have confirmed by isolating the trh
gene tracheal enhancers. Although we cannot discard the presence of cryptic STAT binding
sites that diverge from the ideal consensus we used in our analysis, such elements will probably
have a minor contribution as ignoring their existence allowed us finding the main regulatory
elements. Analysis of only eight fragments comprising a seventh of the trh locus was sufficient
to find the early tracheal STAT92E responsive elements. This analysis uncovered that the locus
extends at least 40 kb upstream the trh promoter, with some enhancers located beyond the first
predicted neighboring gene.
In both the trh and vvl genes we found that other late tracheal enhancers are associated to
STAT92E conserved sites suggesting that the STAT92E protein may be repeatedly used to
control tracheal gene expression during development. This possibility is backed by the fact
that upd is transcribed up to st13 and phosphorylated STAT92E can be detected in the trachea
well after the st10 early specification stage (Harrison et al., 1998; Li et al., 2003). This late
trachea specific expression of upd depends on trh (Bridget Lovegrove and JC-GH unpublished)
suggesting that a feed-back loop maintains JAK/STAT activity during tracheal development.
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We confirmed that the expression of the vvl1+2 early tracheal enhancer depends on STAT92E
by mutating its putative STAT92E binding sites. Our results show that mutation of all three
putative STAT92E sites in the vvl1+2 enhancer causes a severe loss of expression, indicating
that we isolated a bona-fide direct enhancer. However, other possible direct enhancers like the
vvlds1.5 hindgut element show an unexpected behavior. While vvlds1.5 perfectly recapitulates
the vvl early hindgut activation its expression does not stop at st15, but keeps transcribing
lacZ up to st17 well after the endogenous vvl gut transcription ceased. Despite this abnormal
behavior, and pending direct site mutagenesis confirmation, we believe that our experiments
show convincingly that the analysis of the genomic regions containing conserved STAT
binding site clusters is an efficient way to quickly identify direct STAT92E regulated
enhancers.
An important finding of our analysis has been the observation that STAT regulated enhancers
can be tens of kilobases away from the transcriptional start of the target gene, even separated
by another predicted gene. This indicates that STAT regulated enhancers can be functional at
great distances and that search of STAT binding sites should not be restricted to the immediate
vicinity of a gene.
Conserved STAT92E site clustering
Assuming there was no base content bias, the probability of finding in the genome either a
3n or a 4n STAT92E site by chance is (2 × 1/46) which is close to one site every 2 kb. In the
144 kb vvl genomic region there are 85 putative STAT92E sites, that is, 15 more than the
expected 70 sites. Similarly, in the 70 kb trh locus there are 53 putative sites, 19 more than the
expected 34 sites. The excess of sites found can be partially explained by selective pressure as
there are 20 conserved sites in vvl. However, in the trh locus the 9 conserved STAT92E sites
represent only half of the observed excess. An additional explanation for the excess STAT92E
sites could be provided by the observation that in the regions were we found evidence for JAK/
STAT regulation, there are clusters of conserved and non-conserved sites. It has been suggested
that STAT site clustering helps forming tetramers that co-operatively increase STAT
transcriptional output (Bergad et al., 1995; Ota et al., 2004; Xu et al., 1996). Although
STAT92E may form similar tetrameres in Drosophila, the distance of the clustered sites we
observe here is probably too large to allow tetramer formation and their existence must serve
another purpose. When we subdivide the vvl1+2 enhancer we observe that the distal non-
conserved STAT92E site is dispensable for the enhancer function (compare Fig. 5H and I).
However mutagenesis of the two conserved sites in vvl1+2 without mutating the distal non-
conserved site has a mild decrease in the enhancer expression (Fig. 5C). Only when we mutate
all three sites, including the non-conserved site, there is a strong effect on vvl1+2 expression
(Fig. 5D). This shows that non-conserved sites may be functional in vivo even though they are
not absolutely necessary. Our results indicate that sites appearing distal to a STAT92E
regulated enhancer may substitute for the proximal conserved sites, suggesting a way in which
novel functional sites could eventually substitute conserved sites during evolution.
The crb and dome genes, which have been shown in vivo to be STAT92E targets (Lovegrove
et al., 2006; Rivas et al., 2008), also show an accumulation of STAT92E sites in the introns
where the enhancers localize. In the case of dome, five STAT92E sites cluster in a 700 bp
fragment. Although only two of the five sites are conserved, and dissection of the enhancer
showed that the conserved sites are crucial for JAK/STAT regulation, the non-conserved sites
were also required for full enhancer expression (Rivas et al., 2008). Therefore, clustered
conserved and non-conserved STAT92E sites contribute to target gene regulation. It will be
important to understand how STAT92E proteins binding to these distant sites interact with
other transcriptional co-factors that presumably bind to the core enhancer.
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STAT92E and the evolution of arthropod respiratory system
The earliest genes activated specifically in the tracheal primordia are trh and vvl. Both genes
have cross-regulatory interactions that help maintain each other's expression in the trachea, but
their early activation is independent of each other. Here we have localized the early trachea
enhancers in trh and vvl and have shown that their activation in both cases depends on the JAK/
STAT pathway making STAT92E the most important trachea activator. St10 upd expression
is consistent with a model where trh and vvl activation in the tracheae primordia is specified
by a competitive interaction between the JAK/STAT and the WNT signaling pathways.
STAT92E is probably acting with some other transcription factor(s) as inactivation of the JAK/
STAT pathway does not result in a complete lack of expression of the enhancers (Figs. 2H–I
and 6E-G). These other transcription factors would not necessarily have a restricted spatial
expression as the precise positional activation of vvl could be provided by upd and wg. Although
the early requirement of STAT92E for early tracheal specification precludes any studies at
later stages, the maintained expression of upd in later tracheal development and the presence
of STAT92E conserved sites associated to late tracheal enhancers suggest that the pathway is
important for vvl and trh expression maintenance during tracheal development.
The observation that in crustaceans trh and vvl are co-expressed in the epipods that form the
gills suggest that both genes where co-opted early in arthropod evolution to control the
formation of the respiratory system (Franch-Marro et al., 2006). It would be interesting to find
out if JAK/STAT is also required for trh and vvl expression in the crustaceans as that would
suggest that the pathway had been adopted early in evolution fixing the regulation of both genes
in the respiratory system.
Appendix A Supplementary data
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1.
vvl expression in wild type and mutant backgrounds. All embryos show vvl RNA in situ
expression except (F) that shows trh RNA expression. (A–D) Wild type vvl RNA expression.
(A) At early st10 vvl is transcribed in the primordia of the 10 tracheal pits (black arrowheads
in T2 and A8 mark the first and last primordia) and in homologous cells in segments that will
not form trachea (white arrowheads). (B) At st11 10 dorsal epithelial patches (black arrow)
appear in each trunk segment displaced with respect to the tracheal primordia (black
arrowhead). (C) At st14 epithelial expression has spread to almost all the trunk although certain
cells, like some in the posterior spiracles, never express vvl. The anterior hindgut (white
arrowhead) also expresses vvl from st11. (D) At st15 high levels of vvl are expressed in the
trachea and in a group of cells migrating dorsally (white arrows in C and D) that will join the
ring gland. (E) vvl RNA in situ in a Dfvvl 7247-Mis12 embryo lacking most of the vvl
downstream region showing absence of hindgut expression (white arrowhead). (F) trh RNA
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in situ in a wild type st10 embryo showing expression in the salivary gland primordium
(asterisk) and in the 10 tracheal pits (black arrowheads mark the first and last pit primordia).
(G) Ventro lateral view of a wild type st11 embryo showing vvl expression in the tracheal pit
(black arrowhead) and the dorsal patch (arrow). (H) In null hop mutant embryos at st11 vvl is
not expressed in the tracheal pits (arrowhead), while the dorsal patches (arrow) and the midline
expression develop normally. (I) Similarly, in null stat92E mutant embryos vvl is not expressed
at st11 in the tracheal pits (arrowhead), while the dorsal patches (arrow) develop normally. (J)
Dfvvl4 embryos with deleted upstream region have no tracheal expression at st10 until at st11
they start developing very weak vvl expression in the tracheal pits (arrowhead). (K) Cartoon
depicting the vvl genomic region. The intronless vvl transcript is located at 27 kb from CG32392
and at 117 kb from Prat2. The orange box represents the 7 kb area analyzed in previous works
that uncovered the autoregulatory RX-drf enhancer. Red arrows mark the position of the early
trachea enhancers, green arrow the position of the hindgut enhancer. Blue triangles represent
the FRT piggyBac transposable elements used to delete the upstream and downstream cis-
regulatory region (blue lines).
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Fig. 2.
Upstream vvl embryonic enhancers in wild type and upd mutant background. (A) Cartoon
showing the location of the upstream vvl enhancers analyzed. Vertical lines represent putative
STAT92E binding sites. An asterisk marks sites conserved in all 10 studied Drosophilids.
Orange line represents the upstream region analyzed previously (Certel et al., 1996). Red lines
represent the early tracheal enhancers. Green line represents the oenocyte enhancer. Horizontal
blue line indicates the deleted upstream region in Dfvvl4. (B–G) Expression of the indicated
enhancers in wild type embryos. (H–M) Expression of the same enhancers in Dfos1A embryos
lacking all three upd ligands. Note the strong effect that lack of upd has on vvl1+2 and
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vvl345 expression (H–I). Black arrowheads point to the tracheal pits, white arrowheads point
to the homologous patches in anterior and posterior segments.
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Fig. 3.
Downstream vvl embryonic enhancers in wild type and upd mutant backgrounds. (A) Cartoon
representing the location of the downstream vvl enhancers analyzed. Symbols are as in Fig. 2.
(B–F) Expression of the indicated enhancers in wild type embryos. (H–L) Expression of the
same enhancers in a Dfos1A embryos lacking all three upd ligands. (K–L) Note the strong
effect that lack of upd has on vvlds1.5 hindgut expression. (G) Ectopic upd results in ectopic
vvlds1.5 expression in the most posterior area of the hindgut (small arrowheads) and in the
salivary glands. (M) In null hop mutant embryos vvlds1.5 is not expressed in the hindgut
(arrowhead).
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Fig. 4.
Expression of early vvl tracheal enhancers in various mutant backgrounds. (A–G) vvl1+2
expression and (H–N) vvl345 expression. (A) lacZ RNA in situ of a wild type vvl1+2 st10
embryo showing the expression in the tracheal primordia (black arrowheads point the primordia
in T2 and in A8) and in the anterior and posterior spots that will not form trachea (white
arrowheads). (B) lacZ RNA in situ of a vvl1+2 st15 embryo showing the enhancer is not
expressed at later stages. (C) ß-Gal expression of a vvl1+2 st15 wild type embryo. Note that
long-lived ß-Gal perduring expression can be still detected in the trachea and in a group of
cells moving dorsally (Arrows). (D) In vvl mutants vvl1+2 is activated but the expressing cells
do not form normal trachea. (E) In trh mutant embryos ß-Gal expressing cells do not invaginate
staying on the embryo's epidermal surface. (F) In wg mutant embryos vvl1+2 expression is not
restricted to the tracheal primordia. Note that levels of expression are still lower outside the
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normal pit position. (G) vvl1+2 expression is almost missing in hop mutants lacking maternal
and zygotic JAK. (H) lacZ RNA in situ of a vvl345 st10 embryo showing the expression in the
tracheal primordia (black arrowheads point the primordia in T2 and in A8). The expression in
the homologous spots in anterior segments is very weak (white arrowheads). (I) lacZ RNA in
situ of a vvl345 st15 embryo showing that the enhancer is not expressed any longer. (J) ß-Gal
expression of a vvl345 st15 embryo. The perduring protein can be detected by the antibody.
(K) In vvl mutants vvl345 is activated but the invaginated cells do not fuse into a tracheal tree.
(L) In trh mutants vvl345 is expressed but the cells remain on the embryonic epidermis. (M)
In wg mutants vvl345 expression is not restricted to the tracheal pits. (N) vvl345 expression is
almost missing in hop mutants lacking maternal and zygotic JAK. (A–B, H–I) show lacZ RNA
in situ. (C–G, J–N) show anti-ßGal.
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Fig. 5.
Expression of the vvl1+2 early tracheal enhancers is controlled by STAT92E signaling. (A)
Scheme of vvl1+2 and subfragments tested. Black boxes represent blocks of conserved
sequence in all 10 Drosophila species analyzed (see supplementary Fig.1 for sequence). Red
rectangles represent the location of the three putative STAT92E DNA-binding sites. Only two
of the sites are located in conserved blocks while the third one is only present in D.
melanogaster. (B) Wild type vvl 1+2 expression at st10. (C) ß-Gal expression driven from a
vvl 1+2 construct where the two conserved putative STAT92E binding sites have been mutated.
Expression is lower than in the wild type, especially anterior to the second abdominal segment,
but substantial levels of expression remain. (D) ß-Gal expression driven from a vvl 1+2
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construct with all three putative STAT92E binding sites mutated. Expression is highly reduced
but traces still remain. (G) The vvl1+2 MiniS1 fragment does not drive tracheal expression.
(H) vvl MiniS2 drives tracheal expression in embryos at st11. The expression seems to be less
restricted with some ectopic signal between the pits. (I) The vvl1+2 MiniS3 fragment does not
drive tracheal expression. (E, J) A wild type st10 embryo double stained to show the upd RNA
expression (purple) and the vvl RNA expression (brown). (J) is a magnification of E that has
been rotated 180 degrees to have dorsal up and anterior left. Note the continuous upd stripe
(purple arrows) running along the antero-posterior axis of the embryo just ventral to the vvl
tracheal expression. (F) Scheme of the embryo shown in E that has been rotated 180° like panel
J to have dorsal up and anterior left in the region of interest. Besides the tracheal pits and
upd expression the scheme shows the location of the wg expressing cell stripes. (K) Scheme
of proposed negative and positive regulation of early enhancers in the tracheal placodes. (B–
D, G–I) Embryos are stained with anti-ßGal antibody. (E, J) show upd RNA in purple and
vvl RNA in brown.
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Fig. 6.
trh embryonic enhancers in wild type and mutant backgrounds. (A) Cartoon representing the
location of the trh enhancers analyzed. Vertical lines represent putative STAT92E binding
sites. An asterisk marks sites conserved in all Drosophilids. Black boxes represent the analyzed
regions. Arrows indicate transcribed regions. Note that CG13885 nests inside the trh cis-
regulatory region. (B–D) Expression of three early trh tracheal enhancers in a wild type
background. (E–G) Expression in Dfos1A embryos of the same enhancers shown in (B–D).
Most expression disappears from trh66 and trh67 while substantial signal is still present in
trh47. (H) Posterior (white arrow) and anterior spiracle (black arrows) expression driven by
trh24, there is also some expression in the pharyngeal ectoderm (asterisk). (I) Expression of
the trh45 late trachea enhancer. (J) Expression of trh67 in a wingless mutant background.
Lateral views with head left dorsal up in all embryos except H that shows a frontal section.
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Fig. 7.
Expression of early trh tracheal enhancers in various mutants. (A–C) ß-Gal expression of the
early enhancers at st13, all lines delineate the internalized tracheal network. (D–F) Expression
of the early trh trachea enhancers is not affected in homozygous vvl mutant embryos despite
the aberrant migration of the tracheal cells. (G–H) Expression of the trh47 and trh66 is
maintained in trh mutant embryos with the uninvaginated ectodermal cells remaining on the
embryo surface. (I) Expression of the trh67 enhancer requires trh function suggesting a strong
degree of autoregulation. (J–L) Expression of trh47 and trh66 in double vvl trh mutant embryos
is maintained, while trh67 is absent. Embryos in panels A–I are homozygous for the reporter
constructs while in panels J–L are heterozygous.
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